A citation-based method for searching scientific literature

Dennis McGonagle, Iain B McInnes, Atul Deodhar, Georg Schett, May Shawi, Shelly Kafka, Chetan S Karyekar, Alexa P Kollmeier, Elizabeth C Hsia, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Christopher T Ritchlin, Proton Rahman, Philip J Mease. Rheumatology (Oxford) 2021
Times Cited: 2







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.
M Rudwaleit, D van der Heijde, R Landewé, N Akkoc, J Brandt, C T Chou, M Dougados, F Huang, J Gu, Y Kirazli,[...]. Ann Rheum Dis 2011
918
100

Randomized controlled trial of adalimumab in patients with nonpsoriatic peripheral spondyloarthritis.
Philip Mease, Joachim Sieper, Filip Van den Bosch, Proton Rahman, P Mahinda Karunaratne, Aileen L Pangan. Arthritis Rheumatol 2015
56
100

Biological DMARD efficacy in psoriatic arthritis: a systematic literature review and meta-analysis on articular, enthesitis, dactylitis, skin and functional outcomes.
Numa Simons, Yannick Degboé, Thomas Barnetche, Alain Cantagrel, Adeline Ruyssen-Witrand, Arnaud Constantin. Clin Exp Rheumatol 2020
8
50



Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review.
Victoria Navarro-Compán, Chamaida Plasencia-Rodríguez, Eugenio de Miguel, Petra Diaz Del Campo, Alejandro Balsa, Jordi Gratacós. RMD Open 2017
20
50

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.
Désirée van der Heijde, Xenofon Baraliakos, Lianne S Gensler, Walter P Maksymowych, Vira Tseluyko, Oleg Nadashkevich, Walid Abi-Saab, Chantal Tasset, Luc Meuleners, Robin Besuyen,[...]. Lancet 2018
134
50

Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis.
Stan C Kieskamp, Davy Paap, Marlies J G Carbo, Freke Wink, Reinhard Bos, Hendrika Bootsma, Suzanne Arends, Anneke Spoorenberg. Rheumatology (Oxford) 2021
5
50

Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double-Blind Withdrawal Study.
Laura C Coates, Sreekumar G Pillai, Hasan Tahir, Ivo Valter, Vinod Chandran, Hideto Kameda, Masato Okada, Lisa Kerr, Denise Alves, So Young Park,[...]. Arthritis Rheumatol 2021
6
50

Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison.
Jean-Guillaume Letarouilly, Benoît Flachaire, Céline Labadie, Maéva Kyheng, Nicolas Cohen, Jérémie Sellam, Pascal Richette, Philippe Dieude, Pascal Claudepierre, Bruno Fautrel,[...]. Rheumatology (Oxford) 2021
6
50

Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study.
Anna Moltó, Adrien Etcheto, Désirée van der Heijde, Robert Landewé, Filip van den Bosch, Wilson Bautista Molano, Ruben Burgos-Vargas, Peter P Cheung, Eduardo Collantes-Estevez, Atul Deodhar,[...]. Ann Rheum Dis 2016
126
50

Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort.
Raphael Micheroli, Christoph Tellenbach, Almut Scherer, Kristina Bürki, Karin Niederman, Michael J Nissen, Pascal Zufferey, Pascale Exer, Burkhard Möller, Diego Kyburz,[...]. Ann Rheum Dis 2020
25
50

Psoriatic Arthritis.
Christopher T Ritchlin, Robert A Colbert, Dafna D Gladman. N Engl J Med 2017
613
50

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.
Josef S Smolen, Monika Schöls, Jürgen Braun, Maxime Dougados, Oliver FitzGerald, Dafna D Gladman, Arthur Kavanaugh, Robert Landewé, Philip Mease, Joachim Sieper,[...]. Ann Rheum Dis 2018
329
50

Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction.
Robert Bm Landewé, Désirée van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip E Van den Bosch, Karl Gaffney, Lars Bauer, Bengt Hoepken, Owen R Davies, Natasha de Peyrecave,[...]. Ann Rheum Dis 2020
32
50

Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial.
James Cheng-Chung Wei, Tae-Hwan Kim, Mitsumasa Kishimoto, Naoki Ogusu, Haeyoun Jeong, Shigeto Kobayashi. Ann Rheum Dis 2021
14
50

A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis.
Peter C Taylor, Désirée van der Heijde, Robert Landewé, Shannon McCue, Sue Cheng, Annelies Boonen. J Rheumatol 2021
2
50

Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial.
Iain B McInnes, Frank Behrens, Philip J Mease, Arthur Kavanaugh, Christopher Ritchlin, Peter Nash, Jordi Gratacós Masmitja, Philippe Goupille, Tatiana Korotaeva, Alice B Gottlieb,[...]. Lancet 2020
91
50

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study.
Dominique Baeten, Mikkel Østergaard, James Cheng-Chung Wei, Joachim Sieper, Pentti Järvinen, Lai-Shan Tam, Carlo Salvarani, Tae-Hwan Kim, Alan Solinger, Yakov Datsenko,[...]. Ann Rheum Dis 2018
186
50

Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis.
Philip J Mease, Alice B Gottlieb, Désirée van der Heijde, Oliver FitzGerald, Alyssa Johnsen, Marleen Nys, Subhashis Banerjee, Dafna D Gladman. Ann Rheum Dis 2017
122
50

Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial.
Emilie Ducourau, Theo Rispens, Marine Samain, Emmanuelle Dernis, Fabienne Le Guilchard, Lucia Andras, Aleth Perdriger, Eric Lespessailles, Antoine Martin, Grégoire Cormier,[...]. RMD Open 2020
23
50


Conventional disease-modifying antirheumatic drugs therapy may not slow spinal radiographic progression in ankylosing spondylitis: results from an 18-year longitudinal dataset.
Tae-Han Lee, Bon San Koo, Bora Nam, Ji Seon Oh, Seo Young Park, Seunghun Lee, Kyung Bin Joo, Tae-Hwan Kim. Ther Adv Musculoskelet Dis 2020
5
50

Nonsteroidal Antiinflammatory Drug Use and Association With Incident Hypertension in Ankylosing Spondylitis.
Jean W Liew, Michael M Ward, John D Reveille, Michael Weisman, Matthew A Brown, MinJae Lee, Mohammed Rahbar, Susan R Heckbert, Lianne S Gensler. Arthritis Care Res (Hoboken) 2020
9
50

Exercise for ankylosing spondylitis: An evidence-based consensus statement.
Janet R Millner, John S Barron, Kirsty M Beinke, Rachael H Butterworth, Briony E Chasle, Lindsay J Dutton, Margaret A Lewington, Errol G S Lim, Tony B Morley, Jennie E O'Reilly,[...]. Semin Arthritis Rheum 2016
61
50

Diagnostic delay in axial spondyloarthritis: A cross-sectional study of 432 patients.
Vanina Masson Behar, Maxime Dougados, Adrien Etcheto, Sarah Kreis, Stéphanie Fabre, Christophe Hudry, Sabrina Dadoun, Christopher Rein, Edouard Pertuiset, Bruno Fautrel,[...]. Joint Bone Spine 2017
37
50

The window of opportunity: a relevant concept for axial spondyloarthritis.
Philip C Robinson, Matthew A Brown. Arthritis Res Ther 2014
33
50

Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis.
Adeline Ruyssen-Witrand, Richard Perry, Clare Watkins, George Braileanu, Gayathri Kumar, Sandeep Kiri, Debby Nott, Soyi Liu-Leage, Susanne Hartz, Christophe Sapin. RMD Open 2020
28
50


Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration.
Brigitte Michelsen, Ulf Lindström, Catalin Codreanu, Adrian Ciurea, Jakub Zavada, Anne Gitte Loft, Manuel Pombo-Suarez, Fatos Onen, Tore K Kvien, Ziga Rotar,[...]. RMD Open 2020
13
50

Comorbid pain in axial spondyloarthritis, including fibromyalgia.
Clementina López-Medina, Anna Moltó. Ther Adv Musculoskelet Dis 2020
7
50

Current Smoking Is Increased in Axial Psoriatic Arthritis and Radiographic Sacroiliitis.
Dilek Solmaz, Umut Kalyoncu, Ilaria Tinazzi, Sibel Bakirci, Ozun Bayindir, Atalay Dogru, Ediz Dalkilic, Gezmis Kimyon, Cem Ozisler, Gozde Yildirim Cetin,[...]. J Rheumatol 2019
3
50

Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y).
Robert Bm Landewé, Lianne S Gensler, Denis Poddubnyy, Proton Rahman, Maja Hojnik, Xiaoqi Li, Soyi Liu Leage, David Adams, Hilde Carlier, Filip Van den Bosch. Ann Rheum Dis 2021
9
50

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial.
Anna Molto, Clementina López-Medina, Filip E Van den Bosch, Annelies Boonen, Casper Webers, Emanuelle Dernis, Floris A van Gaalen, Martin Soubrier, Pascal Claudepierre, Athan Baillet,[...]. Ann Rheum Dis 2021
26
50

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, Maarten de Wit, Iain McInnes, Maxime Dougados, Jette Primdahl, Dennis G McGonagle, Daniel Aletaha, Andra Balanescu,[...]. Ann Rheum Dis 2020
307
50

Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis.
Jean W Liew, Irvin J Huang, Diana N Louden, Namrata Singh, Lianne S Gensler. RMD Open 2020
7
50

Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study.
Elizabeth G Araujo, Matthias Englbrecht, Sabrina Hoepken, Stephanie Finzel, Eleni Kampylafka, Arnd Kleyer, Sarah Bayat, Verena Schoenau, Axel Hueber, Juergen Rech,[...]. Semin Arthritis Rheum 2019
66
50

Spondyloarthritis: a window of opportunity?
Pascal Claudepierre. Joint Bone Spine 2014
20
50

Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study.
Atul Deodhar, Ricardo Blanco, Eva Dokoupilová, Stephen Hall, Hideto Kameda, Alan J Kivitz, Denis Poddubnyy, Marleen van de Sande, Anna S Wiksten, Brian O Porter,[...]. Arthritis Rheumatol 2021
58
50

Remission in axial spondyloarthritis: The ultimate treatment goal?
Daniel Wendling, Clément Prati. Joint Bone Spine 2016
6
50

Vascular involvement in axial spondyloarthropathies.
Clément Prati, Céline Demougeot, Xavier Guillot, Maxime Sondag, Frank Verhoeven, Daniel Wendling. Joint Bone Spine 2019
8
50


Updates on Axial Psoriatic Arthritis From the 2020 GRAPPA Annual Meeting.
Dafna D Gladman, Philip S Helliwell, Denis Poddubnyy, Philip J Mease. J Rheumatol Suppl 2021
2
50

Effects of anti-IL-23 and anti-IL-17: The hidden side of spondyloarthritis polymorphism?
Daniel Wendling, Clément Prati, Mickael Chouk, Frank Verhoeven. Joint Bone Spine 2020
9
50

Spondyloarthritis: A concept or a disease?
Daniel Wendling, Pascal Claudepierre, Clément Prati, Maxime Dougados. Joint Bone Spine 2015
25
50

Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis.
Andreas Kerschbaumer, Josef S Smolen, Maxime Dougados, Maarten de Wit, Jette Primdahl, Iain McInnes, Désirée van der Heijde, Xenofon Baraliakos, Louise Falzon, Laure Gossec. Ann Rheum Dis 2020
28
50

Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial.
Laura C Coates, Anna R Moverley, Lucy McParland, Sarah Brown, Nuria Navarro-Coy, John L O'Dwyer, David M Meads, Paul Emery, Philip G Conaghan, Philip S Helliwell. Lancet 2015
270
50

2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
Michael M Ward, Atul Deodhar, Lianne S Gensler, Maureen Dubreuil, David Yu, Muhammad Asim Khan, Nigil Haroon, David Borenstein, Runsheng Wang, Ann Biehl,[...]. Arthritis Rheumatol 2019
248
50

Effect of biologics on radiographic progression of peripheral joint in patients with psoriatic arthritis: meta-analysis.
Dongze Wu, Chen Li, Shuo Zhang, Priscilla Wong, Yihan Cao, James F Griffith, Xinlu Zhang, Jieruo Gu, Lai-Shan Tam. Rheumatology (Oxford) 2020
8
50

Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus.
Laure Gossec, Anna Molto, Xavier Romand, Déborah Puyraimond-Zemmour, Matthieu Lavielle, Catherine Beauvais, Eric Senbel, René-Marc Flipo, Sophie Pouplin, Christophe Richez,[...]. Joint Bone Spine 2019
22
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.